General Announcement::Announcement
Issuer & Securities
Issuer/ Manager
JUBILANT PHARMA LIMITED
Securities
JUBILANTP US$200M6%N240305 - XS1958658509 - KBSB
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
28-May-2022 20:06:12
Status
New
Announcement Sub Title
Announcement
Announcement Reference
SG220528OTHRZ7PW
Submitted By (Co./ Ind. Name)
Shyam S Bhartia
Designation
Chairman and Managing Director
Effective Date and Time of the event
29/04/2022 17:00:00
Description (Please provide a detailed description of the event in the box below)
Cooperative Agreement Of US$149.6 Million With US Government For Expansion Of Critical Vaccine Manufacturing Capacity By Jubilant Hollisterstier LLC, USA, A Wholly-Owned Subsidiary Of The Company
Attachments
JPL_SGX_Disclosure_May_28_2022.pdf
Total size =687K
Related Announcements
Related Announcements